CapForce (OPGN) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
23 Feb, 2026Opening remarks and agenda
Meeting called to order at 8:00 A.M. EST, serving as the 2025 annual meeting, with plans to hold the 2026 meeting in the following year.
Meeting hosted virtually to increase inclusivity and reach more stockholders.
Introduction of directors, officers, and independent auditors in attendance.
Stockholders instructed to direct questions to investor relations; no live Q&A held.
Board and executive committee updates
Five directors nominated: Victor Chua Kok Hoe, John Tan Hon Jian, Ken Lim Zhao Qi, Ethan Loh Yu-Jie, and Constance Wong Po Yin.
No other nominations made; nominations declared closed.
Shareholder proposals
Seven proposals presented: election of directors, approval of 2026 Equity Incentive Plan, issuance of up to 889,274 shares upon warrant exercise, ratification of 7.2 million share sale to AEI Capital Limited, company name change, advisory vote on executive compensation, and ratification of accounting firm.
Latest events from CapForce
- Net loss increased to $0.7 million in Q1 2026, with no revenue and continued reliance on external financing.OPGN
Q1 202612 Jun 2026 - 2025 revenue jumped to $30.2M, net income reached $23.6M, led by fintech and advisory growth.OPGN
Q4 20251 Jun 2026 - Shareholders will vote on seven key proposals, including a new equity plan and company name change.OPGN
Proxy Filing6 Feb 2026 - Shareholders will vote on key governance, compensation, and structural changes, including a name change.OPGN
Proxy Filing26 Jan 2026 - Q2 2025 revenue reached $4.0M from listing sponsorship, with net income of $3.5M.OPGN
Q2 202531 Oct 2025 - OpGen posted $8.9M Q3 net income, exited diagnostics, and secured $9M equity funding for fintech pivot.OPGN
Q4 202313 Jun 2025 - OpGen's revenue collapsed and liquidity remains critical as it pursues a sale or strategic transaction.OPGN
Q2 202413 Jun 2025 - Revenue plunged 82% as OpGen pivots to survival mode amid insolvencies and urgent funding needs.OPGN
Q1 202413 Jun 2025